A Prospective Study of Immune Response After COVID‐19 or Vaccination and Correlation Between Avidity Index and Neutralizing Capacity
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Emma Löfström, Anna Eringfält, Arne Kötz, Wanda Christ, Stefan Kunkel, Johan Tham, Jonas Klingström, Johan Undén |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Avidity maturation of anti‐spike IgG after vaccination in COVID‐19 convalescent vs COVID‐19 naïve patients
by: Emma Löfström, et al.
Published: (2024)
by: Emma Löfström, et al.
Published: (2024)
Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian Adolescents
by: Samuel Asamoah Sakyi, et al.
Published: (2024)
by: Samuel Asamoah Sakyi, et al.
Published: (2024)
Discovery of a Novel Public Antibody Lineage Correlated With Inactivated SARS‐CoV‐2 Vaccine and the Resultant Neutralization Activity
by: Jing Wang, et al.
Published: (2024)
by: Jing Wang, et al.
Published: (2024)
Antigenic Imprinting and Immune Response Dynamics: Neutralization Against Emerging SARS‐CoV‐2 Omicron Variants Following Breakthrough Infections
by: Jianhua Li, et al.
Published: (2025)
by: Jianhua Li, et al.
Published: (2025)
Antibody and B‐Cell Responses to PHH‐1V81 XBB.1.16‐Adapted SARS‐CoV‐2 Booster Vaccination Are Associated With Variant Neutralization
by: Cèlia Torres, et al.
Published: (2025)
by: Cèlia Torres, et al.
Published: (2025)
Oral Ad5 Vector‐Based SARS‐CoV‐2 Vaccine Effectively Induces Mucosal and Systemic Immune Responses in BALB/c Mice
by: Tongyao Mao, et al.
Published: (2025)
by: Tongyao Mao, et al.
Published: (2025)
Myeloid‐Driven Immune Suppression Subverts Neutralizing Antibodies and T Cell Immunity in Severe COVID‐19
by: Cong Lai, et al.
Published: (2025)
by: Cong Lai, et al.
Published: (2025)
Neutralizing Antibody and T‐Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1‐Adapted mRNA COVID‐19 Vaccine in Immunosuppressed and Healthy Individuals
by: Ángela Sánchez‐Simarro, et al.
Published: (2025)
by: Ángela Sánchez‐Simarro, et al.
Published: (2025)
A Herpes Simplex Virus Type‐1‐Derived Influenza Vaccine Induces Balanced Adaptive Immune Responses and Protects Mice From Lethal Influenza Virus Challenge
by: Paul J. F. Rider, et al.
Published: (2024)
by: Paul J. F. Rider, et al.
Published: (2024)
Antibody Response to Influenza Hemagglutinin Conserved Stalk Domain after Sequential Immunization with Old Vaccine Strains
by: Alita Kongchanagul, et al.
Published: (2024)
by: Alita Kongchanagul, et al.
Published: (2024)
Beyond Rotavirus: Persistence of Norovirus, Adenovirus, and Astrovirus in Paediatric Gastroenteritis in the Republic of Congo After Vaccine Introduction
by: Cedeche Lebraiche Durain Mboungou, et al.
Published: (2026)
by: Cedeche Lebraiche Durain Mboungou, et al.
Published: (2026)
A Novel Circular Delta‐XBB.1.5 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elicits an Immune Response and Protection Against Multiple SARS‐CoV‐2 Variants in Mice
by: Kangyin Li, et al.
Published: (2024)
by: Kangyin Li, et al.
Published: (2024)
Association of Viraemic Phase Viral Load, Antibody Responses, and Immune Biomarkers With Severe Dengue
by: Kalichamy Alagarasu, et al.
Published: (2026)
by: Kalichamy Alagarasu, et al.
Published: (2026)
Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever Patients
by: André N. A. Gonçalves, et al.
Published: (2024)
by: André N. A. Gonçalves, et al.
Published: (2024)
Epidemiology of Hepatitis B and C Infections in Al‐Anbar/Iraq and Correlation Between Viral Load and Liver Function
by: Mohammed A. Hamad, et al.
Published: (2025)
by: Mohammed A. Hamad, et al.
Published: (2025)
Vaccination Coverage Against Coronavirus Disease 2019 in People Living on Quilombos in Brazil and Its Association With the Human Development Index and the Quality of the Health System
by: Patrícia Teixeira Costa, et al.
Published: (2025)
by: Patrícia Teixeira Costa, et al.
Published: (2025)
Seronegative Vaccinees May Not Benefit From Multiple Booster Doses of MMR Vaccine in Restoring Immunity
by: Gabriele Anichini, et al.
Published: (2024)
by: Gabriele Anichini, et al.
Published: (2024)
Heterologous Versus Homologous COVID‐19 Boosters: Immune Response Outcomes in Renal Transplant Recipients
by: Yesim Yildiz, et al.
Published: (2024)
by: Yesim Yildiz, et al.
Published: (2024)
SFTSV NSs Sequesters the Complex of SFTSV NP‐SAFA to Suppress SAFA Mediated Immune Response
by: Xin‐bo Huang, et al.
Published: (2025)
by: Xin‐bo Huang, et al.
Published: (2025)
Crosstalk Between Viral Envelop‐E Protein and Host Innate Immune System: Exploring Pharmacological Targets and Agents
by: Satyam Shekhar, et al.
Published: (2025)
by: Satyam Shekhar, et al.
Published: (2025)
Low Specific T‐Cell Immunity Against Mpox Elicited in People With HIV‐1 and PrEP Users After Subcutaneous Vaccination Compared to Natural Infection
by: Olivia de la Calle‐Jiménez, et al.
Published: (2025)
by: Olivia de la Calle‐Jiménez, et al.
Published: (2025)
Global Vaccine Confidence at a Crossroads: Immunisation Coverage Declines, Misinformation, and the Future of Vaccine Policy
by: Alfi Sophian, et al.
Published: (2026)
by: Alfi Sophian, et al.
Published: (2026)
Subset Remodeling of MAIT and NK Cells Correlates With Immune Reconstitution in People Living With HIV Following Four Years of Antiretroviral Therapy
by: Zhuoya Deng, et al.
Published: (2025)
by: Zhuoya Deng, et al.
Published: (2025)
Microplastics and Nanoplastics as Carriers for Viral Transmission: Effects on Viral Properties, Infection, Immune Response, and Public Health
by: Cosmina Mija, et al.
Published: (2026)
by: Cosmina Mija, et al.
Published: (2026)
Risk Factors for Breakthrough Acute SARS‐CoV‐2 Infections in Fully Vaccinated Individuals: A Case‐Control Study Nested in a Prospective Cohort in Medelln, Colombia
by: Olga H. Hernández‐Ortiz, et al.
Published: (2025)
by: Olga H. Hernández‐Ortiz, et al.
Published: (2025)
Plaque Characteristics of Circulating Chikungunya Virus Clinical Isolates Correlate With Initial Viral Load, Antibody, and Immune Mediators as Indicators of Disease Outcome
by: Shakuntala Mahilkar, et al.
Published: (2025)
by: Shakuntala Mahilkar, et al.
Published: (2025)
Varicella‐Zoster Virus‐Specific Cell‐Mediated Immune Response Kinetics and Latent Viral Load Depending on Aging
by: Hyo‐Ju Son, et al.
Published: (2025)
by: Hyo‐Ju Son, et al.
Published: (2025)
Xmas‐NT: A Novel Two‐Color Fluorescence Micro Neutralization Test for the Detection of Neutralizing Antibodies Against Monkeypox Virus
by: Clemens Bodenstein, et al.
Published: (2025)
by: Clemens Bodenstein, et al.
Published: (2025)
Acute Flaccid Paralysis in a Vaccinated Child With Primary Immunodeficiency: Difficulties With Diagnostics of Vaccine‐Associated Paralytic Poliomyelitis
by: Armen K. Shakaryan, et al.
Published: (2025)
by: Armen K. Shakaryan, et al.
Published: (2025)
CircCBP Inhibits Influenza A Virus Replication by Interfering the vRNP Activity and Enhancing Antiviral Immune Response
by: Xinli Yao, et al.
Published: (2025)
by: Xinli Yao, et al.
Published: (2025)
A Single‐Cell Atlas Revealed Altered B Cells and Neutrophils Immune Signatures and Inflammatory Responses in SFTSV Infection
by: Qiujing Wang, et al.
Published: (2025)
by: Qiujing Wang, et al.
Published: (2025)
Hepatitis B Vaccination Coverage and Vaccine‐Associated Immunity Among US‐Born Children and Adolescents: NHANES 2017–2020
by: Yihao Lin, et al.
Published: (2026)
by: Yihao Lin, et al.
Published: (2026)
Rotavirus Vaccine Breakthrough With Vaccine‐Modified Disease in a Sibling Cluster of Equine‐Like G3P[8] Infection
by: Ahmad Syatir Tahar, et al.
Published: (2026)
by: Ahmad Syatir Tahar, et al.
Published: (2026)
Immune Reprogramming by EBV and KSHV in the Tumour Microenvironment: From Mechanisms of Immune Escape to Immunotherapy
by: Yang Yu, et al.
Published: (2026)
by: Yang Yu, et al.
Published: (2026)
Proteasome Inhibition Reactivates Latent HIV‐1 and Boosts NK Cell Killing via HLA‐E Downregulation
by: Thessa Laeremans, et al.
Published: (2026)
by: Thessa Laeremans, et al.
Published: (2026)
Global and Regional Burden of Vaccine‐Associated Transverse Myelitis and Potentially Associated With Vaccines From 1967 to 2023: An Analysis of the International Pharmacovigilance Data
by: Jae E. Lee, et al.
Published: (2025)
by: Jae E. Lee, et al.
Published: (2025)
Virus‐Like Nanoparticles for Vaccine Development and Drug Delivery
by: De‐feng Li, et al.
Published: (2026)
by: De‐feng Li, et al.
Published: (2026)
Chronic High Epstein‐Barr Viral Load Carriage Is Positively Correlated With Tacrolimus Intra‐Patient Variability After Pediatric Liver Transplantation
by: Anrui Wang, et al.
Published: (2025)
by: Anrui Wang, et al.
Published: (2025)
Recombinant Zoster Vaccine Reduces All‐Cause Mortality, But Not Major Adverse Cardiovascular Events, in Patients With Immune‐Mediated Inflammatory Diseases Receiving Janus Kinase Inhibitors: A Large‐Scale Real‐World Retrospective Cohort Study
by: Po‐Cheng Shih, et al.
Published: (2025)
by: Po‐Cheng Shih, et al.
Published: (2025)
Evaluation of the GeneTex U‐OK SARS‐CoV‐2 Neutralizing Antibody Detection Assay: Comparison With GenScript cPass and Viral Neutralization Assays
by: Hui‐Ju Lin, et al.
Published: (2025)
by: Hui‐Ju Lin, et al.
Published: (2025)
Similar Items
-
Avidity maturation of anti‐spike IgG after vaccination in COVID‐19 convalescent vs COVID‐19 naïve patients
by: Emma Löfström, et al.
Published: (2024) -
Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian Adolescents
by: Samuel Asamoah Sakyi, et al.
Published: (2024) -
Discovery of a Novel Public Antibody Lineage Correlated With Inactivated SARS‐CoV‐2 Vaccine and the Resultant Neutralization Activity
by: Jing Wang, et al.
Published: (2024) -
Antigenic Imprinting and Immune Response Dynamics: Neutralization Against Emerging SARS‐CoV‐2 Omicron Variants Following Breakthrough Infections
by: Jianhua Li, et al.
Published: (2025) -
Antibody and B‐Cell Responses to PHH‐1V81 XBB.1.16‐Adapted SARS‐CoV‐2 Booster Vaccination Are Associated With Variant Neutralization
by: Cèlia Torres, et al.
Published: (2025)